IRIDEX
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1212 Terra Bella Ave, Mountain View, Cal...Phone Number
(650) 940-4700Website
www.iridex.comRevenue
$52.6 MillionStock Symbol
IRIXIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About IRIDEX
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. IRIDEX is headquartered in Mountain View, California.Explore more
IRIDEX Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is IRIDEX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if IRIDEX had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if IRIDEX has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when IRIDEX launches new products
IRIDEX, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on IRIDEX recently announced quarterly report
Funding: Get notified immidiatlly once IRIDEX has new funding data
Congratulate Masked Content for being promoted to Masked Content at IRIDEX
Check out if IRIDEX is spiking on competitors!
Recommended Actions
Find VP level buyers at IRIDEX
Find 2 more new buyers
Compare Similar Companies to IRIDEX
Compare insights from companies similar to IRIDEX, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
51-200
Private
$8.6M
2002
RM
Richard Mejia JrDirector, Audt Comittee Chair, and Comp Committee Member.
Company Profile Activity
Activity Insights
IRIDEX is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
IRIDEX is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about IRIDEX.
IRIDEX financials insights
Gather financial insights about IRIDEX, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$2M
2021
Other Financing Round
$10M
2025
Stock Offering
$10M
IRIDEX Tech Stack
A closer look at the technologies used by IRIDEX
Most Recent Scoops
Earnings
IRIDEX has reported that, comparing Q1 2024 to Q1 2026, operating expenses declined by $2.7 million or 34%, operating losses improved by $3 million or 90%, adjusted EBITDA remained positive in Q1 2026, and cash at quarter end was $4.6 million.
Earnings, Finance
Person-Based
Earnings, Sales, Finance
Person-Based
Romeo Dizon Chief Financial Officer, participated in the company's Q4 2025 earnings conference call.
Executive Moves, Earnings, Finance
Person-Based
Earnings, Finance
Person-Based
Corporate Strategy, Finance, Financial Operations
IRIDEX News & Media
Iridex Reports Second Quarter 2026 Financial Results
MOUNTAIN VIEW, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today reported financial results for the second quarter ended July 4, 2026.Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
MOUNTAIN VIEW, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to release financial results for the second quarter 2026 and provide a business update after the close of trading on August 18, 2026.Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
MOUNTAIN VIEW, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced the expansion of its EyeProGPO product offering to include the Company’s line of EndoProbe® Handpieces.Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
MOUNTAIN VIEW, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced plans to participate in the upcoming Planet MicroCap Las Vegas 2026 Conference.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding IRIDEX
Sign Up For FreeTo access detailed company insights
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. IRIDEX is headquartered in Mountain View, California.... Read More
